Strategic Investment MDisrupt recently secured milestone-based funding from American Heart Association Ventures and has a growing investor footprint, signaling stronger financial backing and credibility to engage health tech partners, payors, and clinical stakeholders.

Healthcare Market Focus As a premier expert marketplace for health tech and life sciences with access to clinicians, health system executives, and payor leaders, there are clear sales opportunities to offer enterprise access, vendor partnerships, and continued expert networks for product validation and regulatory strategy.

Expansion Signals Notable recent funding rounds and high-profile partnerships (California Health Care Foundation collaboration) indicate momentum and potential for co-development, pilot programs, and expanded service footprints with health systems and research organizations.

Tech-Driven Advantage MDisrupt’s AI-powered platform and diverse on-demand expert roster present a compelling value proposition for clients seeking faster regulatory counsel, market access planning, and clinical trial design, suggesting upsell opportunities for premium analytics and structured engagement solutions.

Cross-Sell Potential With revenue in the multi-million range and a broad expert network, there are opportunities to cross-sell to pharma, medical device companies, and health system suppliers looking for rapid access to clinicians, CMOs, regulatory experts, and health economists for reimbursement strategy and commercialization support.